Practical Strategies for the Early Management
of Type 2 Diabetes

Left to Right:
Stanley H. Hsia, MD
Martin S. Lipsky, MD
Melissa Sujak, RD, LDN, CDE

Module 1: Distinguishing between type 1 and type 2 diabetes

Module 2: Strategies for the patient poorly compliant with nutrition and lifestyle

Module 3: TZDs: Clear as mud?

Module 4: Statins and diabetes: Is it really that simple?

Introduction

Dr Stanley Hsia, Division of Endocrinology and Metabolism, Charles R. Drew University of Medicine and Science and Dr. Martin Lipsky, Department of Family and Community Medicine, University of Illinois College of Medicine at Rockford, engage in a clinical exchange that features a topical discussion of the challenges facing primary care physicians in the diagnosis of early-age onset diabetes, the issues raised by the meta analysis data linking the TZD, rosaglitazone, to increased myocardial infarction, and the current use of statin therapy to reduce cardiovascular risk in the diabetic patient. They are joined by Ms. Melissa Sujak, a registered dietician and certified diabetes educator, to share practical strategies to enhance lifestyle/behavior change, and to improve nutrition education and adherence to physical activity regimens in the poorly compliant patient.

Intended Audience

This continuing medical education program is intended for primary care physicians and other healthcare professionals who manage patients with type 2 diabetes.

Educational Objectives

After completing this activity, participants should be better able to:

Recognize the challenges in distinquishing between type 1 and type 2 diabetes mellitus in early-age onset diabetes.
Recommend effective lifestyle measures in the poorly compliant diabetes patient
Interpret the current data regarding the risk of myocardial infarction with TZDs
Appraise the appropriate use of lipid reducing strategies to prevent cardiovascular events in the patient with type 2 diabetes.

Information on CME credit

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Medical Association designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nonphysicians may receive a certificate of participation for completing this activity.

Instructions for CME credit

This online enduring material is presented as a video webcast with attendant slide presentation. To receive credit, please view all of the presentations of this CME activity and evaluate the content presented. Complete both the pre- and post-test and activity evaluation.

The estimated time to complete this activity, including pre-test, review of the materials, and self-assessment and evaluation is 1.0 hour.

Principal Faculty

Stanley H. Hsia, MD, FRCPC, FACE, Planning Committee, Author and Presenter
Program Director, Endocrinology, Metabolism & Molecular Medicine
Assistant Professor of Medicine, Division of Endocrinology and Metabolism
Charles R. Drew University of Medicine and Science
UCLA School of Medicine
Los Angeles, CA

Daniel Einhorn, MD, FACP, FACE, Planning Committee, Content Reviewer
Medical Director, Scripps Whittier Institute for Diabetes
Clinical Professor of Medicine, UCSD
President, Diabetes and Endocrine Associates
La Jolla, CA

Martin S. Lipsky, MD, Planning Committee, Author and Presenter
Dean, University of Illinois College of Medicine at Rockford
Professor, Department of Family and Community Medicine
Rockford, IL

Melissa Sujak, RD, LDN, CDE, Author and Presenter
Diabetes Program Coordinator
Wellness Institute
Northwestern Memorial Hospital
Chicago, IL

Col. Robert A. Vigersky, MD, Planning Committee, Content Reviewer
Director, Diabetes Institute
Walter Reed Health Care System
Clinical Associate Professor, Department of Medicine
Georgetown University School of Medicine
Washington, DC

R. Mark Evans, PhD, Planning Committee, Content Reviewer
Director, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Kristi Eidsvoog, PhD, Planning Committee, Independent Content Reviewer
Content Manager
Chicago, IL

Patti Fitzgerald, Planning Committee, Content Reviewer
Manager, Product Development, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Disclosure Policy

In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, the AMA requires that all faculty and planning committee members disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being presented. We therefore obtain a completed disclosure and attestation form to inform the participant of any pertinent relationships disclosed, provided here.

These materials have been peer-reviewed by the members of the CME Advisory Board and the AMA Editorial Board to ensure the continued scientific accuracy and medical relevance of information presented and its independence from commercial bias. The AMA has control over all final

Dr. Einhorn: Research Grants, Aventis, Allergan, Lilly, Medtronic, Pfizer, sanofi-aventis;
Consultant, Amylin, Lilly, MannKind, Medtronic, Takeda; Speaker's Bureau,
Amylin, Merck, sanofi-aventis, Takeda; Significant Shareholder, MannKind.

Dr. Hsia: Consultant, Merck

Dr. Lipsky: Nothing relevant to disclose

Ms. Sujak: Nothing relevant to disclose

Dr. Vigersky: Research Grants, DexCom, NovoNordisk, Pfizer, Roche; Stockholder, Merck

Dr. Eidsvoog: Nothing relevant to disclose

Dr. Evans: Nothing relevant to disclose

Ms. Fitzgerald: Nothing relevant to disclose

Acknowledgement of Support

This CME publication was supported through an independent education grant from Takeda Pharmaceuticals and produced in accordance with the AMA Standards for Industry-Supported Multimedia Continuing Medical Education and Other Communications.